Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells

Chiara Nembrini, Brian Abel, Manfred Kopf, Benjamin J. Marsland

Research output: Contribution to journalArticleResearchpeer-review

Abstract

T cell effector function is a central mechanism of adaptive immunity, and accordingly, protection of the host against pathogens. One of the primary effector molecules produced by T cells in response to such pathogens is the cytokine, IFN-γ. Although the signaling pathways associated with the production of IFN-γ are well established, disparate in vivo and in vitro results indicate that distinct pathways may become more prominent dependent upon the nature of the infection, inflammatory milieu and tissue localization. We have examined the roles and requirements of the major IFN-γ-inducing pathways in vivo and in vitro, specifically: strength of TCR signal; paracrine release of IL-12, IL-23, and IL-18; and autocrine production of IFN-γ. Our data show a dynamic interaction between these activation pathways, which allows the host a degree of flexibility and redundancy in the induction of IFN-γ. Upon strong signaling through the TCR, IL-12, IL-18, and IL-23 play negligible roles in the induction of IFN-γ, whereas autocrine IFN-γ is an important component in sustaining its own secretion. However, the absence of any one of these factors during a weaker TCR signal, results in strikingly impaired T cell IFN-γ production. Of note, TLR-activated dendritic cells (DCs) were capable of overcoming the absence of a strong TCR signal, IL-12, IL-23, or IL-18 revealing an important additional mechanism for ensuring a robust IFN-γ response. Our findings clarify the hierarchical requirements of the major IFN-γ inducing pathways and highlight the important role TLR ligand-activated DCs have to preserve them.

Original languageEnglish
Pages (from-to)7180-7188
Number of pages9
JournalJournal of Immunology
Volume176
Issue number12
DOIs
Publication statusPublished - 15 Jun 2006
Externally publishedYes

Cite this

@article{de18286d64fd45ea955590f4473dcdca,
title = "Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells",
abstract = "T cell effector function is a central mechanism of adaptive immunity, and accordingly, protection of the host against pathogens. One of the primary effector molecules produced by T cells in response to such pathogens is the cytokine, IFN-γ. Although the signaling pathways associated with the production of IFN-γ are well established, disparate in vivo and in vitro results indicate that distinct pathways may become more prominent dependent upon the nature of the infection, inflammatory milieu and tissue localization. We have examined the roles and requirements of the major IFN-γ-inducing pathways in vivo and in vitro, specifically: strength of TCR signal; paracrine release of IL-12, IL-23, and IL-18; and autocrine production of IFN-γ. Our data show a dynamic interaction between these activation pathways, which allows the host a degree of flexibility and redundancy in the induction of IFN-γ. Upon strong signaling through the TCR, IL-12, IL-18, and IL-23 play negligible roles in the induction of IFN-γ, whereas autocrine IFN-γ is an important component in sustaining its own secretion. However, the absence of any one of these factors during a weaker TCR signal, results in strikingly impaired T cell IFN-γ production. Of note, TLR-activated dendritic cells (DCs) were capable of overcoming the absence of a strong TCR signal, IL-12, IL-23, or IL-18 revealing an important additional mechanism for ensuring a robust IFN-γ response. Our findings clarify the hierarchical requirements of the major IFN-γ inducing pathways and highlight the important role TLR ligand-activated DCs have to preserve them.",
author = "Chiara Nembrini and Brian Abel and Manfred Kopf and Marsland, {Benjamin J.}",
year = "2006",
month = "6",
day = "15",
doi = "10.4049/jimmunol.176.12.7180",
language = "English",
volume = "176",
pages = "7180--7188",
journal = "Journal of Immunology",
issn = "0022-1767",
publisher = "American Association of Immunologists",
number = "12",

}

Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. / Nembrini, Chiara; Abel, Brian; Kopf, Manfred; Marsland, Benjamin J.

In: Journal of Immunology, Vol. 176, No. 12, 15.06.2006, p. 7180-7188.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells

AU - Nembrini, Chiara

AU - Abel, Brian

AU - Kopf, Manfred

AU - Marsland, Benjamin J.

PY - 2006/6/15

Y1 - 2006/6/15

N2 - T cell effector function is a central mechanism of adaptive immunity, and accordingly, protection of the host against pathogens. One of the primary effector molecules produced by T cells in response to such pathogens is the cytokine, IFN-γ. Although the signaling pathways associated with the production of IFN-γ are well established, disparate in vivo and in vitro results indicate that distinct pathways may become more prominent dependent upon the nature of the infection, inflammatory milieu and tissue localization. We have examined the roles and requirements of the major IFN-γ-inducing pathways in vivo and in vitro, specifically: strength of TCR signal; paracrine release of IL-12, IL-23, and IL-18; and autocrine production of IFN-γ. Our data show a dynamic interaction between these activation pathways, which allows the host a degree of flexibility and redundancy in the induction of IFN-γ. Upon strong signaling through the TCR, IL-12, IL-18, and IL-23 play negligible roles in the induction of IFN-γ, whereas autocrine IFN-γ is an important component in sustaining its own secretion. However, the absence of any one of these factors during a weaker TCR signal, results in strikingly impaired T cell IFN-γ production. Of note, TLR-activated dendritic cells (DCs) were capable of overcoming the absence of a strong TCR signal, IL-12, IL-23, or IL-18 revealing an important additional mechanism for ensuring a robust IFN-γ response. Our findings clarify the hierarchical requirements of the major IFN-γ inducing pathways and highlight the important role TLR ligand-activated DCs have to preserve them.

AB - T cell effector function is a central mechanism of adaptive immunity, and accordingly, protection of the host against pathogens. One of the primary effector molecules produced by T cells in response to such pathogens is the cytokine, IFN-γ. Although the signaling pathways associated with the production of IFN-γ are well established, disparate in vivo and in vitro results indicate that distinct pathways may become more prominent dependent upon the nature of the infection, inflammatory milieu and tissue localization. We have examined the roles and requirements of the major IFN-γ-inducing pathways in vivo and in vitro, specifically: strength of TCR signal; paracrine release of IL-12, IL-23, and IL-18; and autocrine production of IFN-γ. Our data show a dynamic interaction between these activation pathways, which allows the host a degree of flexibility and redundancy in the induction of IFN-γ. Upon strong signaling through the TCR, IL-12, IL-18, and IL-23 play negligible roles in the induction of IFN-γ, whereas autocrine IFN-γ is an important component in sustaining its own secretion. However, the absence of any one of these factors during a weaker TCR signal, results in strikingly impaired T cell IFN-γ production. Of note, TLR-activated dendritic cells (DCs) were capable of overcoming the absence of a strong TCR signal, IL-12, IL-23, or IL-18 revealing an important additional mechanism for ensuring a robust IFN-γ response. Our findings clarify the hierarchical requirements of the major IFN-γ inducing pathways and highlight the important role TLR ligand-activated DCs have to preserve them.

UR - http://www.scopus.com/inward/record.url?scp=33744903126&partnerID=8YFLogxK

U2 - 10.4049/jimmunol.176.12.7180

DO - 10.4049/jimmunol.176.12.7180

M3 - Article

VL - 176

SP - 7180

EP - 7188

JO - Journal of Immunology

JF - Journal of Immunology

SN - 0022-1767

IS - 12

ER -